TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Verastem Shares Are Exploding 50% -- Here's Why
HEALTH

Verastem Shares Jump On Cancer Drug Data - Biotech Movers

  • By Armie Margaret Lee
  • Sep 6, 2017 11:11 AM EDT
PRESS RELEASES

Merrimack Reports Second Quarter 2020 Financial Results

  • By Business Wire
  • Aug 7, 2020 8:20 AM EDT
PRESS RELEASES

Merrimack Reports First Quarter 2020 Financial Results

  • By Business Wire
  • May 7, 2020 6:10 PM EDT
PRESS RELEASES

Merrimack Divests Early Stage Asset For $2.25 Million; Provides Strategy Update

  • By Business Wire
  • Apr 2, 2020 8:30 AM EDT
PRESS RELEASES

Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan

  • By Business Wire
  • Dec 3, 2019 4:15 AM EST
PRESS RELEASES

Merrimack Receives $5 Million Milestone Payment From Ipsen; Declares $6.7 Million Special Dividend

  • By Business Wire
  • Dec 3, 2019 3:45 AM EST
Verastem Shares Are Exploding 50% -- Here's Why
HEALTH

Verastem Shares Jump On Cancer Drug Data - Biotech Movers

  • By Armie Margaret Lee
  • Sep 6, 2017 11:11 AM EDT
Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
HEALTH

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers

  • By Armie Margaret Lee
  • Aug 31, 2017 9:39 AM EDT
Bristol-Myers Stock
HEALTH

Biotech Movers: Array Shares Rise on Bristol-Myers Collaboration

  • By Armie Margaret Lee
  • May 30, 2017 9:29 AM EDT
Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

Trevena, Synergy Lead Biotech Movers

  • By Alicia McElhaney
  • Apr 6, 2017 10:32 AM EDT
Trump Policies to Ignite Earnings Recovery, Stock Prices in 2017
STOCKS

These 5 Stocks Under $10 Could Explode Up Soon

  • By Roberto Pedone
  • Mar 2, 2017 1:21 PM EST
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
STOCKS

Immunomedics, Seattle Genetics lead biotech movers on deal news

  • By Alicia McElhaney
  • Feb 10, 2017 9:14 AM EST
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
STOCKS

Here are the the biotech stocks moving ahead of the opening bell

  • By Alicia McElhaney
  • Jan 26, 2017 9:25 AM EST
So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
FUTURES

So the Nasdaq is at a historical high but the Dow is going opposite direction

  • By Keris Alison Lahiff
  • Jan 9, 2017 5:41 PM EST
Closing Bell: Alibaba's Ma Meets With Trump; Nasdaq Hits Record
VIDEO

Closing Bell: Alibaba's Ma Meets With Trump; Nasdaq Hits Record

  • By Keris Alison Lahiff
  • Jan 9, 2017 4:21 PM EST
San Francisco Power Outage Affects 90,000
STOCKS

The Monday sights, sounds and biotech buzz from the J.P. Morgan Healthcare Conference

  • By Adam Feuerstein
  • Jan 9, 2017 3:55 PM EST
Wall Street's Decline Puts Record-Making Streak in Jeopardy
FUTURES

Nasdaq hits records even as crude selloff sours rest of market

  • By Keris Alison Lahiff
  • Jan 9, 2017 2:44 PM EST
Wall Street's Decline Puts Record-Making Streak in Jeopardy
FUTURES

Dow steps back from 20,000 as crude oil slides

  • By Keris Alison Lahiff
  • Jan 9, 2017 11:10 AM EST
Merrimack Sells Pancreatic Cancer Drug to Ipsen for $1 Billion
VIDEO

Merrimack Sells Pancreatic Cancer Drug to Ipsen for $1 Billion

  • By TheStreet Staff
  • Jan 9, 2017 10:05 AM EST
Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
STOCKS

Biotech stocks surge Monday amid flurry of deal activity

  • By Alicia McElhaney
  • Jan 9, 2017 9:59 AM EST
Market Selloff Strategies: Cramer's 'Mad Money' Recap (Friday 8/18/17)
FUTURES

Stock futures mostly lower as crude oil slides

  • By Keris Alison Lahiff
  • Jan 9, 2017 8:47 AM EST
What to Expect From European Pharmaceuticals' First Quarter Results
MERGERS AND ACQUISITIONS

Merrimack soars on $1 billion sale of cancer drugs to Ipsen

  • By Paul Whitfield
  • Jan 9, 2017 7:13 AM EST
5 Things You Must Know Before the Market Opens Monday
FUTURES

5 things you must know before the market opens Monday

  • By Joseph Woelfel
  • Jan 9, 2017 6:26 AM EST
Stocks Sport Slight Losses as Dow's Journey to 20,000 Pauses
FUTURES

Stocks sport slight losses as Dow's journey to 20,000 pauses

  • By Keris Alison Lahiff
  • Dec 21, 2016 2:32 PM EST
Stocks Ease Off Highs as Dow 20,000 Remains a Challenge
FUTURES

Dow struggles to score 20,000 as Nike earnings fail to deliver big bump

  • By Keris Alison Lahiff
  • Dec 21, 2016 10:40 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.